双特异抗体
- 友芝友生物制药成功实施B+轮融资 2021-01-28
- 原能医学A轮融资超2亿元，加速靶向实体肿瘤产品临床研究 2020-12-18
- TG Therapeutics Announces Proposed Public Offering of Common Stock 2020-12-14
- 友芝友完成近2亿B轮融资， 聚焦肿瘤免疫治疗双抗药物 2020-12-02
- 宜明昂科宣布完成2.4亿元人民币B轮融资 2020-11-11
- 安博生物（Ambrx）完成2亿美元Crossover轮融资，致力于开发精准生物制药 2020-11-10
- 维立志博完成近2亿新一轮融资，加速推进抗肿瘤新药研发 2020-10-29
- Elpis Biopharmaceuticals Debuts with Series A Funding and Establishment of Scientific Advisory Board 2020-10-29
- 时迈药业完成近1.5亿B轮融资，加速双抗药物临床开发 2020-09-27
- LAVA Therapeutics Announces $83 million Series C Financing to Advance Novel Immuno-Oncology Programs 2020-09-17
登录医药魔方官网 查看更多资讯
